for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cooper Companies Inc

coo

Latest Trade

302.32USD

Change

1.07(+0.36%)

Volume

376,717

Today's Range

301.35

 - 

306.37

52 Week Range

228.65

 - 

344.32

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
301.25
Open
301.71
Volume
376,717
3M AVG Volume
6.31
Today's High
306.37
Today's Low
301.35
52 Week High
344.32
52 Week Low
228.65
Shares Out (MIL)
49.57
Market Cap (MIL)
14,934.05
Forward P/E
24.46
Dividend (Yield %)
0.02

Latest Developments

More

Coopercompanies Announces Q3 Non-Gaap Earnings Per Share $3.23

Cooper Companies Reports Q2 Earnings Per Share Of $2.45

The Cooper Companies Announces First Quarter 2019 Results

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cooper Companies Inc

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision, Inc. and CooperSurgical, Inc. CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses. CooperVision services three primary regions: the Americas; Europe, the Middle East and Africa (EMEA), and Asia Pacific. CooperVision offers spherical, aspherical, toric, multifocal and toric multifocal lens products in various modalities. CooperVision's products are primarily manufactured at its facilities located in the United Kingdom, Puerto Rico, Hungary, Costa Rica and New York. CooperSurgical offers an array of products and services focused on advancing the health of families through a portfolio of products and services focusing on women's health, fertility and diagnostics.

Industry

Medical Equipment & Supplies

Contact Info

6140 Stoneridge Mall Rd Ste 590

+1.925.4603600

http://www.coopercos.com/

Executive Leadership

A. Thomas Bender

Independent Chairman of the Board

Albert G. White

President, Chief Executive Officer, Director

Allan E. Rubenstein

Independent Vice Chairman of the Board, Lead Director

Brian G. Andrews

Chief Financial Officer, Senior Vice President, Treasurer

Robert D. Auerbach

President - CooperSurgical

Key Stats

1.80 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

2.0K

2017

2.1K

2018

2.5K

2019(E)

2.6K
EPS (USD)

2016

8.440

2017

9.700

2018

11.500

2019(E)

12.316
Price To Earnings (TTM)
32.34
Price To Sales (TTM)
5.71
Price To Book (MRQ)
4.13
Price To Cash Flow (TTM)
20.05
Total Debt To Equity (MRQ)
50.14
LT Debt To Equity (MRQ)
39.35
Return on Investment (TTM)
8.38
Return on Equity (TTM)
7.47

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up